Skip to main content
Inventage Lab Inc. logo

Inventage Lab Inc. — Investor Relations & Filings

Ticker · 389470 ISIN · KR7389470006 KO Professional, scientific and technical activities
Open in API
Filings indexed 195 across all filing types
Latest filing 2023-12-22 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 389470

About Inventage Lab Inc.

https://www.inventagelab.com/m/en/

Inventage Lab Inc. is a biopharmaceutical company specializing in the development of advanced Drug Delivery Systems (DDS). The company's foundation is its proprietary microfluidics-based platform technology, Laminar-FluiDigm™, which is applied to pharmaceutical research and manufacturing. Inventage Lab operates two primary platforms: IVL-DrugFluidic® for developing and producing microsphere-based long-acting injectables, and IVL-GeneFluidic® for the formulation and manufacturing of Lipid Nanoparticles (LNPs) for nucleic acid and gene therapies. The company's pipeline is focused on treating chronic and refractory diseases, with key programs targeting androgenic alopecia (male pattern baldness) and Alzheimer's disease. Other development areas include drug re-discovery for conditions like rheumatic arthritis and multiple sclerosis, and collaborative projects for HIV treatments and mRNA-based therapies.

Recent filings

Filing Released Lang Actions
[기재정정]반기보고서 (2023.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-annual Report) for the company 'Inventage Lab', which includes detailed financial statements, management discussion, and audit information for the period ending June 30, 2023. It is a comprehensive financial report for a period shorter than a full fiscal year, containing actual financial data and analysis, which fits the definition of an Interim/Quarterly Report (IR). H1 2023
2023-12-22 Korean
[기재정정]분기보고서 (2023.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'Inventage Lab' (주식회사 인벤티지랩). It contains detailed financial statements, notes to financial statements, and management information for the 3rd quarter of 2023. The document explicitly mentions it is a 'Correction Report' (정정신고) regarding the previously submitted 3rd quarter report, providing updated financial data and tables. This falls under the category of an Interim/Quarterly Report (IR). 9M 2023
2023-12-22 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date for a shareholder meeting (주주명부폐쇄기간 또는 기준일 설정). It is a standard corporate disclosure filed with the regulatory authority to inform shareholders of the upcoming record date for the Annual General Meeting. Since it is a specific regulatory notification regarding shareholder rights and meeting preparation, it falls under the general regulatory filing category.
2023-12-14 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) regarding a 'Decision on Paid-in Capital Increase' (유상증자결정). It details the issuance of new shares, conversion prices, and capital structure changes. This falls under the category of share issuance and capital changes.
2023-11-30 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders and special related parties, including the purpose of holding (management influence), contract details, and specific transaction history. This corresponds to the 'Major Shareholding Notification' category.
2023-11-23 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is a mandatory disclosure for company insiders (directors/executives) reporting changes in their personal shareholdings, which corresponds to the 'Director's Dealing' category.
2023-11-23 Korean

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.